comparemela.com

Page 18 - அடைய News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ViewSonic Introduces ToF Technology to its Latest Portable LED Projector M2e to achieve Instant Auto Focus

(1) Complete focus in one second, automatic motion detection and refocus BREA, Calif., Feb. 25, 2021 /PRNewswire/ ViewSonic Corp., a leading global provider of visual solutions, is introducing its latest M2e Instant Smart 1080p Portable LED Projector. This new addition to the company s M series of smart portable LED projectors uses Time-of-Flight (ToF) technology to achieve instant auto focus in an ultralight and portable design. ToF technology enables the M2e to instantly auto focus in only one second, which is 3-5 times faster compared to current methods. It delivers impeccable optical precision, effortless setup, and its portability makes for flexible entertainment and work at home.

Arete Incident Response Achieves Record Sales and Profit Performance in 2020

Arete Incident Response Achieves Record Sales and Profit Performance in 2020 Global Cybersecurity Services Leader Rapidly Accelerates Growth for Third Consecutive Year WEST PALM BEACH, Fla., Feb. 24, 2021 /PRNewswire/ Arete Incident Response, a leading global provider of cybersecurity services and technology to corporations, law firms, insurance carriers, and government entities, announced today that it achieved record sales and profit for the fiscal year ending December 31, 2020. This was the company s third consecutive year of substantial revenue growth with a 320% increase compared to 2019. Our team delivered another year of outstanding performance, said Arete s co-founder and CEO, Joe Mann. We continued to expand our relationships with premier law firms, insurance carriers, corporations, and government clients. Our focus on professional staffing, process automation, training, accuracy, and execution motivated many of our clients to reward us with a larger share of their

Insilico Medicine Achieves Industry First Nominating Preclinical Candidate Discovered by AI

Insilico Medicine Achieves Industry First Nominating Preclinical Candidate Discovered by AI Insilico Medicine Achieves Industry First Nominating Preclinical Candidate for Idiopathic Pulmonary Fibrosis With Both Novel Drug Target and Novel Molecule Discovered by Artificial Intelligence HONG KONG, Feb. 24, 2021 /PRNewswire/ Insilico Medicine has demonstrated a breakthrough in Artificial Intelligence ( AI ) and drug discovery - linking together generative chemistry and biology for the first time - to discover a novel preclinical candidate addressing idiopathic pulmonary fibrosis ( IPF ) and be validated with multiple human cell and animal model experiments. Often found implicated in a wide range of diseases and multiple organs such as lung, liver and kidney, IPF addresses a very broad medical need that affects hundreds of thousands of individuals worldwide.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.